Literature DB >> 18444878

Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes.

N Lee, C S Cockram, P K S Chan, D S C Hui, K W Choi, J J Y Sung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18444878     DOI： 10.1086/533477

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  19 in total

1.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

2.  Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China.

Authors:  Hongjie Yu; Zijian Feng; Timothy M Uyeki; Qiaohong Liao; Lei Zhou; Luzhao Feng; Min Ye; Nijuan Xiang; Yang Huai; Yuan Yuan; Hui Jiang; Yingdong Zheng; Paul Gargiullo; Zhibin Peng; Yunxia Feng; Jiandong Zheng; Cuiling Xu; Yanping Zhang; Yuelong Shu; Zhancheng Gao; Weizhong Yang; Yu Wang
Journal:  Clin Infect Dis       Date:  2011-01-10       Impact factor: 9.079

Review 3.  Rapid Antigen Tests for Influenza: Rationale and Significance of the FDA Reclassification.

Authors:  Daniel A Green; Kirsten StGeorge
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

Review 4.  Influenza and the use of oseltamivir in children.

Authors:  Ergin Çiftçi; Adem Karbuz; Tanıl Kendirli
Journal:  Turk Pediatri Ars       Date:  2016-06-01

5.  Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.

Authors:  Hongjie Yu; Qiaohong Liao; Yuan Yuan; Lei Zhou; Nijuan Xiang; Yang Huai; Xiuhua Guo; Yingdong Zheng; H Rogier van Doorn; Jeremy Farrar; Zhancheng Gao; Zijian Feng; Yu Wang; Weizhong Yang
Journal:  BMJ       Date:  2010-09-28

6.  Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection.

Authors:  Ryan Zarychanski; Tammy L Stuart; Anand Kumar; Steve Doucette; Lawrence Elliott; Joel Kettner; Frank Plummer
Journal:  CMAJ       Date:  2010-01-21       Impact factor: 8.262

7.  Evaluation of diagnostic and therapeutic approaches for suspected influenza A(H1N1)pdm09 infection, 2009-2010.

Authors:  Vini Vijayan; Jennie Jing; Kenneth M Zangwill
Journal:  Emerg Infect Dis       Date:  2012-09       Impact factor: 6.883

8.  Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus.

Authors:  Shi-gui Yang; Bin Cao; Li-rong Liang; Xiao-li Li; Yong-hong Xiao; Zhi-xin Cao; Hong-yu Jia; Hong-jie Yu; Zhen Xu; Li Gu; Yi-da Yang; Yu Chen; Wei-bo Du; Xi-xin Yan; Zong-an Liang; Wei Zhang; Chang-le Zhang; Wei Chen; Cai-ping Guo; Xun-liang Jiang; Ming Yang; Guang-ming Deng; Kai-jiang Yu; Ke Hu; Qi Zou; Lan-juan Li; Chen Wang
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

9.  Symptomatic predictors for 2009 influenza A virus (H1N1) infection with an emphasis for patients with a negative rapid diagnostic test.

Authors:  Chen-Yen Kuo; Yhu-Chering Huang; Chung-Guei Huang; Kuo-Chien Tsao; Tzou-Yien Lin
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

10.  Secondary bacterial infections in patients with seasonal influenza A and pandemic H1N1.

Authors:  Karin Liderot; Marcus Ahl; Volkan Ozenci
Journal:  Biomed Res Int       Date:  2013-06-20       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.